Merck & Co., Inc. (MRK)
| Previous close | 72.17 |
| Open | 72.51 |
| Bid | 72.44 x 900 |
| Ask | 72.46 x 1000 |
| Day's range | 72.01 - 72.93 |
| 52-week range | 65.25 - 87.80 |
| Volume | 4,758,364 |
| Avg. volume | 10,374,976 |
| Market cap | 183.878B |
| Beta (5Y monthly) | 0.43 |
| PE ratio (TTM) | 26.14 |
| EPS (TTM) | 2.78 |
| Earnings date | 29 Apr 2021 |
| Forward dividend & yield | 2.60 (3.60%) |
| Ex-dividend date | 12 Mar 2021 |
| 1y target est | 96.33 |
- Business Wire
Merck Begins Tender Offer to Acquire Pandion Therapeutics
Merck Begins Tender Offer to Acquire Pandion Therapeutics
- Reuters
Biden says 'big mistake' for states to lift mask mandates given virus toll
U.S. President Joe Biden on Wednesday said decisions to end the required wearing of masks - such as those by governors of Texas and Mississippi - amounted to "Neanderthal thinking" given the rising death toll from the coronavirus pandemic. Biden said the increasing availability of vaccinations was making a difference in containing the pandemic, but it was critical to remain vigilant about wearing masks, washing hands and social distancing. Asked about Biden's remarks, Mississippi Governor Tate Reeves told Fox News Channel: "We no longer have a healthcare crisis in our state ... I wish the president would focus on trusting Americans rather than trying to insult Americans."
- Zacks
Merck (MRK) to Help J&J Make COVID-19 Vaccine to Boost Supply
Merck (MRK) will use its existing facilities to manufacture and supply J&J's newly approved COVID-19 vaccine.
